Hypertension Diagnostics Inc (HDII)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 03-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | N/A | N/A | N/A | N/A | -1,401 |
| Depreciation Amortization | N/A | N/A | N/A | N/A | 225 |
| Accounts receivable | N/A | N/A | N/A | N/A | 107 |
| Accounts payable and accrued liabilities | N/A | N/A | N/A | N/A | 267 |
| Other Working Capital | N/A | N/A | N/A | N/A | 461 |
| Other Operating Activity | 0 | 0 | 0 | 0 | -266 |
| Operating Cash Flow | $N/A | $N/A | $N/A | $N/A | $-606 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | N/A | N/A | -250 |
| Other Investing Activity | 0 | 0 | 0 | 0 | 75 |
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $-175 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | N/A | 210 |
| Debt Issued | N/A | N/A | N/A | N/A | 560 |
| Debt Repayment | N/A | N/A | N/A | N/A | -26 |
| Financing Cash Flow | $N/A | $N/A | $N/A | $N/A | $744 |
| Beginning Cash Position | N/A | N/A | N/A | N/A | 75 |
| End Cash Position | N/A | N/A | N/A | N/A | 6 |
| Net Cash Flow | $N/A | $N/A | $N/A | $N/A | $-69 |
| Free Cash Flow | |||||
| Operating Cash Flow | N/A | N/A | N/A | N/A | -606 |
| Capital Expenditure | N/A | N/A | N/A | N/A | -250 |
| Free Cash Flow | 0 | 0 | 0 | 0 | -857 |